-
Pfizer, Moderna, Johnson & Johnson: Comparing the 3 COVID Vaccines Now Available
With three coronavirus vaccines now approved in the U.S., what is the difference between the vaccines and should you opt for one over the other?
-
Pfizer, Moderna, Johnson & Johnson: Comparing the 3 COVID Vaccines Now Available
With a third coronavirus vaccine now approved in the U.S., what is the difference between the vaccines and should you opt for one over the other?
-
Hard Rock Stadium Becomes Appointment-Free Vaccine Site, Expands Hours
People seeking to get a COVID-19 vaccine at Hard Rock Stadium in Miami Gardens will no longer need an appointment starting Monday. FEMA Master Public Information Officer Mike Jachles announced that starting on Monday, Hard Rock Stadium will begin administering the Pfizer vaccine to Florida residents without the need of an appointment. He also announced that the stadium will be…
-
Are You in #PfizerGang? Explaining the Vaccine Rivalries on Social Media
It’s better to get any vaccine than none, but now people are saying “Pfizer’s for hot people”? Vaccine rivalries are playing out on TikTok, as young people get their shots and find community with others who got the same brand’s dose. Kalhan Rosenblatt, NBC News Youth and Internet Culture reporter, explains the trend.
-
Pfizer Requests FDA to Expand Use of COVID-19 Vaccine in Adolescents
Pfizer and its German partner BioNTech have requested the FDA expands the emergency use of their COVID-19 vaccine to include adolescents aged 12 to 15.
-
Pfizer Asks FDA to Expand COVID Vaccine Authorization for Ages 12-15
Pfizer on Friday filed a request with the Food and Drug Administration to expand use of its COVID-19 vaccine to teens ages 12 to 15.
-
See Which States Have Opened COVID Vaccine Eligibility to All Adults
Here’s where vaccination eligibility stands in every state:
-
Federally-Supported Vaccination Sites in Florida Shifting From Pfizer to J&J Shots
Federally-supported vaccination sites in Florida will transition to administrating the Johnson & Johnson one-dose shot next week. “The state has been able to make this change as it receives an increased allocation of the Johnson and Johnson vaccine this week,” a press release read. Starting Tuesday, April 6, the Pfizer vaccine will no longer be available at the sites in…
-
Pfizer Trial Shows Vaccine Effectiveness Against South African Variant
Pfizer and Biontech announced Thursday that their vaccine has proven effective against the coronavirus for at least six months after the second dose, including the South African variant.
-
Pfizer Says COVID-19 Vaccine Is Effective for Kids 12-15
The next frontier in the effort to vaccinate the population, getting shots into the arms of children, took a big step closer to happening Wednesday. Pfizer announced its COVID-19 vaccine is 100% effective in children ages 12 through 15. “As a pediatrician, this is really exciting to find out that the vaccine is very effective for that age group, this…
-
-
Why Isn't the AstraZeneca Vaccine Approved in the U.S.? What to Know About Each Vaccine
Here’s what we know about each of the coronavirus vaccines, and where they’re being distributed.
-
FDA Authorizes Emergency Use of First Single-Shot Vaccine
This makes the Johnson & Johnson vaccine the third vaccine to have emergency use authorization from the U.S. Food and Drug Administration.
-
FDA to Consider Adding Johnson & Johnson Vaccine to Rollout
The FDA could approve a new one-shot COVID vaccine by Friday, as Congress decides on COVID relief bill details. The Johnson & Johnson one-shot vaccine is over 20 percent less effective than Pfizer and Moderna’s, but still far better than a flu shot.
-
Pfizer COVID-19 Vaccine Works Well in Big ‘Real World' Test
A large real-world test of Pfizer’s COVID-19 vaccine confirms that it’s very effective at preventing serious illness or death, even after one dose
-
Drug Executives: Big Jump in Vaccine Supply Coming Soon
COVID-19 vaccine makers tell Congress to expect a big jump in the delivery of doses over the coming month.
-
US Reaches 500K COVID-19 Deaths
The grim milestone means the U.S. continues to lead the world in overall cases and deaths.
-
Pfizer Expected to Cut Vaccine Production Time Almost in Half
It takes Pfizer 110 days to produce a batch of its COVID-19 vaccine. The company says it expects to soon shorten that time to 60 days.
-
Pfizer Ahead of Schedule to Release 200 Million Doses of COVID-19 Vaccine
Pfizer announced on Tuesday that it is months ahead of schedule to deliver 200 million doses of its coronavirus vaccine to the U.S. The shipment should be available to Americans starting in May.
-
New Study Suggests Pfizer/BioNTech Vaccine Works Against New COVID-19 Variants
A new study suggests that Pfizer/BioNtech’s coronavirus vaccine appears to work against new variants that have begun circulating in the U.S. The study has not been peer-reviewed or published in a medical journal.